parasit
plasmodium
falciparum
caus
agent
sever
malaria
human
kill
somewher
million
peopl
year
complex
life
cycl
includ
asexu
prolifer
within
human
erythrocyt
characteris
three
distinct
stage
ring
trophozoit
schizont
adapt
intraerythrocyt
lifestyl
creat
new
case
uniqu
organel
endosomallysosomallik
organel
food
vacuol
fv
review
contrast
organel
mitochondrion
apicoplast
fv
persist
throughout
whole
asexu
intraerythrocyt
life
cycl
discard
end
cycl
analysi
multipl
laboratori
result
sever
compet
model
fv
biogenesi
ring
stage
includ
big
gulp
model
suggest
first
step
fv
biogenesi
initi
uptak
singl
larg
parcel
haemoglobin
follow
continu
uptak
packag
mediat
cytostom
fuse
vesiclelik
fv
addit
contribut
endocytosi
exclud
model
tubu
model
prefer
contribut
cytostom
uptak
haemoglobin
well
yet
contrast
previou
model
theori
vesicleindepend
model
cytostom
initi
pinchoff
form
elong
tube
eventu
fuse
fv
tube
would
initi
enabl
uptak
haemoglobin
contact
cytostom
later
deliv
haemoglobin
fv
pinch
fuse
fv
prefv
model
base
observ
earli
intraerythrocyt
life
stage
multipl
enclos
compart
call
prefv
compart
detect
haemoglobin
degrad
alreadi
start
late
ring
stage
smaller
compart
fuse
give
rise
fv
earli
trophozoit
stage
vesicl
deriv
cytostom
invagin
deliv
fv
continu
suppli
organel
haemoglobin
degrad
haemoglobin
still
verifi
function
fv
studi
extens
protein
compon
haemoglobin
catabolis
via
seri
peptidas
degrad
releas
ferriprotoporphyrin
ix
fp
degrad
malari
parasit
toxic
instead
plasmodium
parasit
polymeris
fp
crystallin
haemozoin
becom
distinct
featur
fv
trophozoit
schizont
parasit
crucial
process
fp
polymeris
target
import
antimalari
drug
best
understood
inhibitori
process
chloroquin
cq
accumul
fv
inhibit
polymeris
haem
haemozoin
either
bind
free
fp
cap
fp
polym
result
accumul
toxic
unpolymeris
fp
toxic
fpcq
complex
although
ongo
discuss
exactli
compound
mediat
parasit
death
chloroquin
enter
parasit
neutral
form
believ
diffus
across
food
vacuol
membran
insid
acid
environ
proton
charg
unabl
freeli
diffus
fv
lead
accumul
chloroquin
insid
food
vacuol
rel
rest
parasit
extern
milieu
chloroquin
resist
parasit
accumul
consider
less
cq
fv
rel
sensit
parasit
differ
accumul
attribut
mutat
fv
membran
protein
pfcrt
particularli
substitut
k
residu
lesser
degre
chang
fv
membran
protein
mean
pfcrt
modul
fv
chloroquin
concentr
much
debat
author
suggest
differ
ph
fv
sensit
resist
parasit
modifi
accumul
drug
eg
howev
recent
studi
indic
sensit
resist
parasit
significantli
differ
fv
acid
modifi
pfcrt
cq
resist
parasit
directli
facilit
leak
chloroquin
fv
data
indic
mutat
pfcrt
allow
charg
cq
escap
fv
efflux
decreas
concentr
cq
fv
nonleth
level
despit
clear
associ
resist
remain
unclear
whether
pfcrt
mutat
suffici
gener
chloroquin
resist
field
mani
chloroquin
resist
isol
polymorph
also
found
transport
regulatori
chang
assort
gene
associ
compens
resist
mutat
pfcrt
even
isogen
line
transfect
parasit
take
sever
week
reach
popul
level
allow
drug
assay
perform
potenti
allow
line
compens
pfcrt
chang
secondari
tran
mutat
epigenet
regulatori
chang
circumv
necessarili
long
delay
transfect
analysi
transgen
parasit
characteris
direct
effect
pfcrt
mutat
gener
isogen
parasit
line
anhydrotetracyclineregulat
express
pfcrtgfp
fusion
use
pfcrt
allel
sensit
pfcrt
resist
parasit
pfcrtr
induc
express
pfcrtgfp
fusion
also
allow
us
characteris
traffick
pfcrt
fv
membran
knowledg
target
protein
toward
fv
recent
restrict
lumen
proteas
particip
haemoglobin
degrad
plasmepsin
ii
fv
lumen
peptidas
plasmepsin
ii
target
via
parasit
plasma
membran
pm
fv
integr
membran
protein
brefeldin
bfa
sensit
manner
wherea
solubl
first
transport
pm
accumul
parasitophor
vacuol
pv
follow
final
transport
step
fv
recent
first
studi
target
pfcrt
publish
demonstr
pfcrt
traffic
fv
membran
via
er
brefeldin
sensit
subsequ
direct
fvm
depend
small
region
cterminu
includ
potenti
phosphoryl
threonin
posit
key
pfcrt
mutat
associ
chloroquin
resist
posit
boundari
protein
first
transmembran
domain
tmd
length
composit
protein
initi
transmembran
length
traffick
determin
endomembran
protein
therefor
examin
whether
chang
charg
transmembran
boundari
pfcrt
affect
subcellular
localis
thu
function
cqresist
form
studi
taken
advantag
induc
express
system
order
overexpress
pfcrt
pfcrtr
gfptag
fusion
protein
within
cq
sensit
plasmodium
parasit
show
pfcrt
form
ident
localis
fv
membran
differenti
subcellular
localis
therefor
caus
differenti
chloroquin
sensit
also
show
pfcrt
traffick
inhibit
dynasor
inhibitor
dynaminmedi
vesicl
format
consist
role
dynamin
fv
biogenesi
induc
gfptag
pfcrt
also
provid
excel
tool
follow
biogenesi
fv
develop
show
exist
pfcrt
envelop
organel
prior
appear
haemozoin
tradit
definit
appear
fv
sequenc
annot
pfcrt
acquir
plasmodb
wwwplasmodborg
characterist
point
mutat
within
first
tmd
pfcrt
cqsensit
strain
cqresist
strain
obtain
fidock
et
al
align
perform
use
clustalw
jalview
predict
tmd
length
posit
pfcrt
pfcrtr
carri
use
predictor
wwwcbsdtudkservicestmhmm
memsat
http
http
sequenc
first
tmd
glycoprotein
avian
coronaviru
infecti
bronchiti
viru
obtain
macham
et
al
helic
wheel
project
perform
use
helic
wheel
applet
creat
edward
k
oneil
charl
grisham
univers
virginia
charlottesvil
virginia
usa
plasmid
gener
replac
drive
transcript
transactiv
deriv
ptgfp
contain
dual
haemagglutinin
epitpop
place
gfp
p
falciparum
gdna
pcr
amplifi
oligonucleotid
cggcttaaggttgtttttctctttgtggtcaaaataag
gctaatattattattctcatctcgagtttttttttttttttaaatgttgaattataaac
result
kb
product
digest
aflii
xhoi
fill
klenow
fragment
subsequ
clone
site
also
fill
klenow
epitop
tag
replac
gfp
creat
vector
provid
uniqu
psti
mlui
restrict
enzym
site
minim
regulat
promot
gfp
creat
induc
gfp
fusion
protein
creat
sequenc
correspond
fulllength
code
region
pfcrt
amplifi
chloroquin
sensit
strain
hereaft
refer
pfcrt
chloroquin
resist
hereaft
refer
pfcrtr
direct
clone
psti
mlui
site
human
erythrocyt
australian
red
cross
blood
servic
melbourn
australia
infect
p
falciparum
parasit
strain
cultur
use
modif
method
establish
trager
jensen
describ
transfect
p
falciparum
parasit
carri
previous
describ
total
plasmiddna
use
per
transfect
electropor
ringstag
parasit
p
falciparum
parasit
transfect
induc
vector
recov
hepesbuff
medium
supplement
sodium
bicarbon
albumax
ii
invitrogengibco
contain
transcript
inhibitor
anhydrotetracyclin
atc
sigmaaldrich
final
concentr
ad
h
post
transfect
complet
medium
final
concentr
select
parasit
plasmid
cultur
incub
atmospher
protein
express
atcrepress
plasmid
induc
follow
parasit
cultur
synchronis
use
sorbitol
min
subsequ
cultur
absenc
transcript
inhibitor
atc
h
follow
parasitaemia
adjust
ringstag
parasit
incub
h
protein
express
gfpepitop
tag
protein
check
use
zeiss
axioplan
imag
univers
microscop
zeiss
parasit
protein
express
induc
discard
use
subsequ
experi
perform
freshli
induc
parasit
popul
neverinduc
parasit
protein
express
gfptag
pfcrt
induc
total
protein
erythrocyt
infect
mainli
schizont
parasit
obtain
lysi
pb
contain
wv
saponin
wv
bsa
min
presenc
edtafre
proteas
inhibitor
roch
protein
parasit
heat
min
presenc
edtafre
proteas
inhibitor
roch
separ
bistri
gel
mop
run
buffer
invitrogen
protein
transfer
hybond
polyvinyliden
fluorid
pvdf
membran
ge
healthcar
life
scienc
gfptag
pfcrt
identifi
mous
antigfp
roch
follow
antimous
hrpconjug
igg
molecular
probe
endogen
gapdh
identifi
rabbit
antigapdh
kind
gift
leann
tilley
univers
melbourn
follow
antirabbit
hrpconjug
igg
molecular
probe
visualis
use
chemiluminesc
system
ecl
pierc
sampl
prepar
live
cell
perform
follow
protein
express
gfptag
pfcrt
induc
erythrocyt
infect
mainli
trophozoit
schizont
parasit
harvest
nuclei
parasit
stain
dapi
nucleic
acid
stain
invitrogen
pb
min
cell
wash
pb
resuspend
pb
immunofluoresc
assay
ifa
perform
previous
describ
protein
express
gfptag
pfcrt
induc
erythrocyt
infect
mainli
trophozoit
schizont
parasit
fix
min
room
temperatur
rt
pb
contain
vv
paraformaldehyd
vv
glutaraldehyd
wash
twice
icecold
pb
permeabilis
triton
pb
min
rt
wash
pb
cell
incub
mous
antigfp
roch
antibodi
wv
bsa
pb
overnight
cell
wash
twice
incub
either
alexa
fluor
alexa
fluor
antibodi
molecular
probe
wv
bsa
pb
h
wash
cell
incub
dapi
nucleic
acid
stain
invitrogen
wv
bsa
pb
min
mount
cell
glass
slide
wash
twice
pb
eventu
resuspend
pb
aliquot
resuspend
cell
mount
glycerol
dabco
sigmaaldrich
glass
slide
cover
cover
slip
coat
polyethylenimin
live
cell
fix
cell
respect
seal
cell
analys
use
zeiss
axioplan
imag
univers
microscop
zeiss
imag
softwar
axiovis
zeiss
erythrocyt
infect
p
falciparum
parasit
treat
either
brefeldin
sigmaaldrich
previous
describ
dynasor
hydrat
sigmaaldrich
previous
describ
brefeldin
mgml
dissolv
ethanol
ad
young
trophozoit
schizont
parasit
express
gfptag
pfcrt
follow
induct
protein
express
final
concentr
incub
h
live
cell
imag
ifa
perform
previous
describ
neg
control
second
parasit
cultur
prepar
way
treat
volum
ethanol
instead
brefeldin
protein
express
gfptag
pfcrt
induc
young
trophozoit
schizont
parasit
treat
dynasor
mm
dissolv
wv
dmso
h
live
cell
imag
ifa
perform
previous
describ
second
parasit
cultur
prepar
way
howev
instead
dynasor
hydrat
volum
vv
dmso
ad
drug
sensit
assay
perform
use
sybr
green
stain
method
hour
growth
previous
describ
smilkstein
et
al
modif
detail
protein
express
sensit
resist
form
pfcrt
gfpfusion
protein
p
falciparum
parasit
induc
describ
second
correspond
parasit
popul
treat
equal
yet
maintain
presenc
transcript
inhibitor
atc
wild
type
parasit
also
assay
parasit
popul
dispens
final
parasitaemia
triplic
tissu
cultur
plate
prepar
vari
cq
concentr
haematocrit
select
agent
case
uninduc
parasit
atc
total
volum
relev
experi
parasit
also
cultur
verapamil
parasit
growth
induc
uninduc
parasit
also
measur
absenc
cq
posit
control
uninfect
erythrocyt
cultur
absenc
cq
atc
provid
background
level
fluoresc
neg
control
parasit
cultur
h
optim
cultur
condit
follow
h
incub
period
cqtreat
parasit
wash
ad
new
tissu
cultur
plate
contain
sybr
green
invitrogen
lysi
buffer
mm
tri
ph
mm
edta
wv
saponin
wv
triton
incub
h
rt
fluoresc
excit
emiss
wavelength
centr
nm
nm
respect
examin
use
thermoscientif
varioskan
flash
micropl
reader
experi
conduct
triplic
experi
perform
independ
five
time
investig
phenotyp
chloroquin
sensit
parasit
express
resist
form
pfcrt
without
delay
would
allow
cryptic
compensatori
mutat
epigenet
chang
gener
atcregulat
construct
pfcrt
fuse
gfp
took
advantag
transactiv
system
establish
meissner
colleagu
allow
repress
express
addit
atc
origin
atcregulat
plasmid
express
transactiv
control
promot
gene
tempor
transcript
peak
schizont
stage
parasit
mimic
tempor
express
pfcrt
modifi
vector
replac
promot
gene
similar
express
phase
abund
pfcrt
gfp
fusion
gener
full
gene
pfcrt
chloroquin
sensit
line
chloroquin
resist
line
contain
among
mutat
replac
figur
western
blot
analysi
use
antigfp
antibodi
mix
parasit
show
band
height
correspond
motil
kda
product
induc
parasit
uninduc
sampl
figur
kda
slightli
smaller
expect
molecular
weight
kda
pfcrt
gfp
fusion
multispan
tm
protein
regularli
migrat
quickli
expect
appar
mass
pfcrt
alon
previous
report
migrat
faster
expect
analys
valid
express
system
induc
product
localis
pfcrt
pfcrtr
figur
previou
localis
studi
pfcrt
report
localis
sole
fv
membran
howev
bioinformat
analysi
pfcrt
pfcrtr
predict
possibl
differ
length
first
tmd
resist
sensit
protein
associ
mutat
posit
two
independ
tmd
predictor
memsat
predict
mutat
found
pfcrt
protein
resist
parasit
particularli
chang
would
chang
length
posit
polar
face
first
transmembran
domain
figur
b
c
even
small
differ
tmd
composit
length
enough
mistarget
protein
earli
stage
secretori
pathway
therefor
investig
whether
mutat
pfcrt
alter
traffick
fv
may
impact
role
modul
drug
resist
live
cell
fluoresc
well
immunofluoresc
assay
perform
use
induc
pfcrtsgfp
fusion
protein
localis
studi
confirm
localis
pfcrt
fv
membran
figur
occasion
parasit
show
minor
addit
fraction
nuclear
peripheri
correspond
pattern
previous
describ
er
localis
fluoresc
signal
remain
strong
whole
intraerythrocyt
life
stage
pfcrtgfp
schizont
stage
parasit
addit
localis
mobil
puncta
within
fv
well
label
fv
membran
may
repres
internalis
vesicl
carri
pfcrtgfp
gfp
alon
degrad
fusion
protein
although
see
gfponli
band
western
blot
localis
pfcrt
pfcrtr
simultan
analys
compar
repeatedli
differ
localis
observ
two
life
stage
figur
form
show
clear
restrict
localis
fv
membran
includ
particular
mention
occasion
er
stain
puncta
within
fv
lumen
older
parasit
result
confirm
induc
express
system
use
studi
capabl
express
form
pfcrt
gfpfusion
mutat
result
alter
localis
pfcrt
focu
previou
studi
pfcrt
either
localis
traffick
fv
membran
studi
focus
trophozoit
parasit
fv
appar
life
cycl
stage
allow
colocalis
haemozoin
crystal
therefor
wish
extend
studi
use
pfcrtgfp
fusion
marker
fv
develop
throughout
asexu
intraerythrocyt
life
cycl
first
express
gfptag
pfcrt
induc
parasit
detect
juxtanuclear
dotlik
structur
mid
late
ring
figur
mid
ring
parasit
dual
localis
nascent
fv
er
frequent
observ
indic
juxtanuclear
puncta
structur
well
fine
ring
around
nucleu
late
ring
stage
parasit
small
sphere
fluoresc
colocalis
round
spheric
bodi
visibl
light
microscopi
yet
stage
still
lack
detect
refractil
dark
haemozoin
crystal
indic
discret
prefv
compart
bear
pfcrt
form
prior
appear
haemozoin
normal
use
morpholog
charact
defin
commenc
trophozoit
stage
figur
stage
follow
enlarg
pfcrtdelin
vacuol
continu
expans
haemozoin
crystal
vacuolar
membran
matur
schizont
stage
second
pfcrtsgfplabel
structur
observ
enlarg
small
ring
structur
either
attach
fv
membran
separ
fv
membran
figur
b
second
ring
structur
adjac
fv
membran
associ
fv
whatsoev
seem
independ
organellar
compart
haemozoin
crystal
also
appar
within
secondari
fvlike
compart
figur
summari
live
cell
microscopi
pfcrtgfp
parasit
reveal
presenc
prefv
compart
prior
detect
haemozoin
crystal
compart
may
origin
parasit
peripheri
also
consist
previouslydescrib
dynam
process
late
stage
parasit
result
second
fv
compart
origin
fv
induc
express
gfptag
pfcrt
use
investig
traffick
rout
pfcrt
fv
membran
treatment
parasit
overexpress
pfcrtsgfp
bfa
perform
order
confirm
use
induc
system
traffick
studi
use
gfptag
pfcrt
bfa
treatment
mainli
trophozoit
schizont
stage
parasit
perform
previous
describ
h
bfa
wherea
control
popul
treat
equival
volum
ethanol
show
restrict
fv
membran
localis
figur
bfatreat
parasit
show
mark
increas
fluoresc
around
nucleu
correspond
er
localis
figur
untreat
parasit
accumul
label
pfcrt
molecul
either
ppm
golgilik
compart
result
consist
previou
studi
dissect
target
process
pfcrt
investig
role
dynaminmedi
vesicl
format
traffick
pfcrt
treat
gfptag
pfcrt
express
parasit
dynamin
gtpase
inhibitor
dynasor
previou
studi
localis
er
fv
wherea
localis
er
golgi
compart
dynasor
treatment
report
disrupt
integr
fv
produc
fragment
organel
treat
malari
parasit
express
gfptag
pfcrt
h
concentr
concentr
report
reduc
gtpase
activ
dynaminlik
enzym
approxim
enabl
parasit
develop
later
stage
wherea
concentr
complet
inhibit
develop
parasit
analysi
parasit
cultur
longer
h
presenc
dynasor
show
clear
differ
morpholog
label
pattern
compar
h
treatment
data
shown
fluoresc
parasit
treat
dynasor
somewhat
lower
indic
toxic
seen
bfa
immunofluoresc
show
gfp
fv
membran
also
increas
accumul
pfcrtsgfp
around
nucleu
treat
parasit
correspond
er
localis
figur
dynasoretr
parasit
show
pattern
pfcrt
perfectli
colocalis
fv
form
long
stringform
associ
exterior
fv
without
embrac
whole
fv
untreat
parasit
data
indic
traffick
pfcrt
via
er
involv
bfasensit
process
previous
shown
also
action
dynaminlik
protein
parasit
induc
overexpress
gfpfusion
pfcrt
pfcrtr
use
investig
differ
sensit
cq
parasit
possess
two
separ
pfcrt
protein
unmodifi
genom
copi
pfcrt
line
well
gfpfusion
either
pfcrt
pfcrtr
episom
poorli
segreg
p
falciparum
parasit
gener
transfect
line
express
desir
product
addit
induc
system
imperfect
small
number
parasit
strongli
express
induc
protein
found
previou
implement
system
moreov
express
pfcrtgfp
fusion
becam
consider
weaker
sever
cycl
induct
preclud
longerterm
experi
establish
parasit
stabli
express
fusion
protein
reason
unclear
may
relat
toxic
longer
express
pfcrtgfp
fusion
variabl
meant
import
care
measur
number
parasit
express
pfcrtgfp
fusion
line
drug
sensit
assay
perform
drug
sensit
assay
soon
possibl
induct
fusion
protein
induct
remov
transcript
inhibitor
atc
sorbitolsynchronis
ring
stage
parasit
allow
overexpress
pfcrtsgfp
pfcrtrgfp
next
ring
stage
synchronis
point
cq
drug
assay
commenc
assess
consist
pfcrtgfp
fusion
express
fluoresc
induc
parasit
monitor
percentag
gfpexpress
parasit
determin
separ
plate
hour
later
averag
parasit
fluoresc
pfcrtsgfp
pfcrtrgfp
line
respect
result
confirm
consist
induc
express
system
addit
demonstr
compar
proport
overexpress
parasit
two
independ
popul
atc
remov
parasit
sensit
cq
follow
use
sybrgreen
assay
parasit
growth
hour
select
agent
maintain
transfect
parasit
total
five
independ
experi
three
intern
replic
valu
wildtyp
parasit
use
experiment
method
averag
nm
parasit
chloroquin
tabl
valu
consist
hour
previous
report
strain
parasit
transfect
pfcrtgfp
plasmid
transgen
express
repress
mainten
atc
show
signific
differ
compar
ttest
p
signific
differ
chloroquin
sensit
observ
parasit
parasit
express
either
pfcrtrgfp
pfcrtsgfp
ttest
p
verapamil
chloroquineresist
revers
agent
restor
much
cq
sensit
cqresist
discern
effect
cq
sensit
pfcrtrgfp
pfcrtsgfp
express
line
tabl
ttest
p
conclud
therefor
fusion
protein
either
impact
chloroquin
resist
suffici
mild
effect
drugrespons
assay
unabl
detect
experi
eukaryot
system
increasingli
made
clear
import
role
tmd
posit
protein
within
cell
protein
endomembran
system
composit
length
transmembran
domain
particularli
initi
membranespan
domain
partial
determin
subcellular
localis
chang
result
mistarget
includ
mutat
alter
length
transmembran
domain
add
remov
polar
face
transmembran
domain
eg
figur
specif
transmembran
domain
also
shown
instrument
traffick
plasmodium
falciparum
major
resist
determin
mutat
pfcrt
end
first
predict
transmembran
domain
multipl
addit
mutat
found
transmembran
domain
pfcrt
modul
resist
chloroquin
quinolon
drug
bioinformat
interrog
mutat
suggest
may
alter
posit
length
initi
transmembran
domain
figur
therefor
test
whether
chang
transmembran
domain
may
modul
resist
plasmodium
chang
subcellular
localis
pfcrt
potenti
alter
subcellular
distribut
chloroquin
chang
rel
amount
transport
food
vacuol
plasma
membran
ergolgi
examin
identicallyprepar
gfp
fusion
resist
sensit
form
pfcrt
conclus
falsifi
hypothesi
differ
abund
localis
two
form
exclus
intracellularli
localis
detect
fraction
plasma
membran
much
like
altern
chang
charg
potenti
orient
chang
membran
span
portion
protein
brought
chang
tmd
length
result
alter
transport
capac
pfcrt
cooper
colleagu
martin
kirk
convincingli
describ
diminish
posit
charg
limit
pfcrt
tmd
polar
face
might
chang
transport
affin
proton
increas
abil
pfcrtr
transport
chloroquin
heterolog
system
strongli
support
model
use
induc
pfcrtgfp
fusion
investig
traffick
rout
induc
protein
fv
membran
kuhn
colleagu
previous
demonstr
pfcrt
traffic
fv
membran
via
ergolgi
use
combin
genet
delet
experi
treatment
parasit
fungal
metabolit
brefeldin
bfa
bfa
interfer
earli
target
event
er
golgi
level
inhibit
function
guanin
nucleotideexchang
gep
protein
regul
activ
adpribosyl
factor
arf
protein
arf
protein
involv
wide
rang
function
includ
regul
er
golgi
function
morpholog
ertogolgi
transport
recruit
cop
adaptor
protein
complex
protein
review
also
examin
bfa
sensit
induc
express
pfcrtgfp
fusion
found
bfa
produc
defect
traffic
ergolgi
fv
membran
consist
traffick
rout
via
ergolgi
figur
one
mean
traffick
vesicl
er
golgi
dynamin
dynaminlik
gtpasemedi
vesicl
bud
plasmodium
sever
dynaminlik
protein
like
involv
organel
divis
endocytosi
other
potenti
involv
vesicl
bud
one
dynamin
homologu
localis
multipl
cellular
destin
includ
fv
er
anoth
report
localis
er
golgi
compart
relict
plastid
role
dynaminlik
gtpase
plasmodium
interrog
use
dynasor
noncompetit
inhibitor
act
dynamin
gtpase
domain
dynasor
report
produc
dramat
effect
plasmodium
endocytosi
haemoglobin
uptak
well
disrupt
lead
profound
fragment
fv
address
whether
dynaminlik
gtpase
involv
target
pfcrt
fv
dynasoretr
parasit
overexpress
pfcrtsgfp
contrast
previou
studi
saw
widespread
morpholog
defect
fv
assay
live
cell
imag
parasit
fv
membran
highlight
pfcrtsgfp
label
figur
experi
fv
intact
fragment
howev
see
disrupt
pfcrtsgfp
target
increas
fluoresc
around
nuclei
correspond
er
localis
figur
suggest
dynaminlik
protein
may
involv
traffick
protein
ergolgi
fv
potenti
action
complet
bud
vesicl
data
also
independ
support
model
ermedi
traffick
mechan
fv
membran
protein
fv
persist
throughout
intraerythrocyt
life
stage
henc
depend
de
novo
biogenesi
follow
invas
new
erythrocyt
current
model
tri
describ
fv
de
novo
biogenesi
occur
endosomallysosomallik
organel
develop
intraerythrocyt
life
cycl
base
observ
variou
microscop
techniqu
avail
fluoresc
marker
fv
membran
meant
abl
identifi
mid
late
ring
stage
parasit
even
haemozoin
crystal
present
earliest
parasit
defin
fv
compart
abu
bakar
colleagu
show
exist
variou
small
prefv
compart
fuse
togeth
form
central
fv
compart
light
microscopi
like
provid
insuffici
resolut
us
abl
identifi
whether
earliest
pfcrt
label
delin
one
small
compart
multipl
small
vesicl
aggreg
experi
use
fluoresc
tracer
erythrocyt
cytoplasm
could
elucid
whether
earliest
pfcrtbound
compart
alreadi
contain
haemoglobin
interest
find
respect
fv
cell
biolog
revel
second
dotlik
structur
ring
structur
besid
fv
ring
localis
later
schizont
stage
parasit
sever
studi
fv
inde
show
neighbour
compart
might
contain
haemozoin
unclear
compart
protrus
fv
whose
connect
invis
dimens
instead
smaller
pfcrtgfp
compart
share
similar
longliv
extrafv
compart
describ
abu
bakar
colleagu
unclear
secondari
compart
deriv
parcel
haemoglobin
cytostom
invagin
alreadi
recruit
pfcrt
fail
fuse
exist
fv
membran
result
pinchingoff
part
fv
result
second
fvlike
compart
anoth
possibl
ident
structur
neutral
lipid
bodi
superfici
similar
appear
neutral
lipid
bodi
visualis
hydrophob
probe
nile
red
previous
link
haemozoin
format
plasmodium
found
within
fv
lumen
schizont
stage
parasit
cytosol
well
howev
associ
pfcrt
neutral
lipid
bodi
detect
western
blot
analysi
neutral
lipid
bodi
furthermor
contrast
multipl
neutral
lipid
bodi
seen
individu
schizont
saw
singl
addit
pfcrt
bound
compart
cell
substanti
emiss
spectrum
overlap
nile
red
gfp
prevent
colocalis
experi
pfcrtgfp
use
avail
imag
equip
despit
clear
causal
relationship
mutat
pfcrt
chloroquin
resist
role
addit
genet
epigenet
factor
acquisit
chloroquin
remain
unclear
partli
line
express
transgen
pfcrt
pfcrt
allel
exchang
week
growth
least
compens
neg
effect
mutant
pfcrt
attempt
studi
whether
sudden
express
mutant
chloroquin
resist
pfcrt
sensit
background
suffici
bestow
chloroquin
resist
use
repress
atc
express
system
howev
valu
obtain
cq
sensit
parasit
overexpress
either
pfcrtsgfp
pfcrtrgfp
show
signific
differ
sever
factor
make
result
difficult
interpret
first
small
percentag
cell
express
fusion
protein
induct
either
cell
line
effect
seen
atcregulat
system
apicomplexan
parasit
system
meant
larg
number
parasit
assay
fact
parent
popul
phenotyp
signal
eman
induc
parasit
would
weaken
background
signal
nonexpress
parasit
nevertheless
gap
drug
sensit
strongli
drug
resist
sensit
line
suffici
substanti
differ
still
appar
chang
even
mix
popul
anoth
possibl
confound
factor
gfp
fusion
pfcrt
may
prevent
function
transport
may
inhibit
interact
chloroquin
initi
intend
studi
induc
overexpress
pfcrt
form
without
gfp
fusion
investig
effect
howev
low
level
parasit
express
induct
meant
experi
would
unreli
without
marker
pfcrt
overexpress
pfcrt
antibodi
avail
none
reliabl
specif
hand
fac
base
sort
fluoresc
parasit
purifi
popul
homogen
express
cell
may
repres
anoth
potenti
experiment
approach
low
number
cell
possibl
recov
sort
experi
may
inappropri
use
drug
sensit
assay
develop
superior
induc
system
p
falciparum
may
also
address
issu
condit
protein
stabilis
system
use
excel
effect
address
sever
question
plasmodium
biolog
applic
system
subcellular
destin
uncertain
pfcrt
marker
protein
fv
membran
proven
import
tool
studi
de
novo
biogenesi
develop
fv
live
plasmodium
parasit
howev
exact
process
underli
de
novo
biogenesi
fv
mechan
haemoglobin
transfer
fv
remain
import
question
address
question
import
compensatori
mechan
allow
pfcrt
mutat
mediat
chloroquin
resist
latter
question
would
particularli
facilit
superior
induc
express
system
enabl
robust
interrog
condit
express
pfcrt
